Guide to Appealing Infected Blood Compensation Decisions in the UK

Understanding the Infected Blood Compensation Appeal Process in the UK

The UK government provides a dedicated pathway for individuals affected by infected blood products to challenge decisions made by the Infected Blood Compensation Authority (IBCA). This process is managed through the HM Courts & Tribunals Service, ensuring that appeals are handled independently and fairly. The official form used for this purpose is the SSCS8, which guides appellants through the necessary steps to seek a review of their compensation decision.

Scope and Purpose of the SSCS8 Form

The SSCS8 form is specifically designed for individuals who wish to appeal against a decision made by the IBCA regarding their claim under the Infected Blood Compensation Scheme (IBCS). After an initial application, the IBCA reviews the case and issues a Review Decision Notice. If the applicant disagrees with this decision, the SSCS8 provides a formal mechanism to escalate the matter to an independent tribunal.

This process is crucial for ensuring transparency and fairness in the handling of sensitive cases involving infected blood. It allows affected individuals or their representatives to formally contest the outcome, providing reasons for disagreement and submitting additional evidence if necessary.

Who Can Use the SSCS8 Appeal Form?

The form can be completed by:

• Individuals directly affected by the infected blood products, seeking to appeal their compensation decision.
• Parents or guardians appealing on behalf of minors or individuals lacking capacity.
• Personal representatives acting on behalf of a deceased person who was affected by infected blood.
• Individuals with power of attorney or other legal authority to act on behalf of an affected person.

It is important to accurately specify your role when submitting the form to ensure the appeal is processed correctly.

Key Elements of the Appeal Process

Preparation and Information Needed

Before completing the SSCS8, appellants should gather essential details, including:

• The Review Decision Notice issued by the IBCA, which contains the outcome of their review.
• Details of any representatives assisting with the appeal, such as legal advisors or advocacy groups.
• The reasons for disagreement with the IBCA’s decision, which can be elaborated as much as necessary.

Submitting the Appeal

The appeal must be submitted by post, following the instructions provided in the official guidance. The form includes sections for personal details, case references, and contact information, ensuring the tribunal can process the appeal efficiently. The appellant also has the option to receive updates via text message, keeping them informed throughout the process.

Support and Additional Resources

Applicants are encouraged to seek help from trusted sources such as local advice centres, Citizens Advice, or legal professionals familiar with infected blood cases. The HMCTS provides a dedicated helpline to answer questions related to the appeal process, although they do not offer legal advice. The helpline numbers vary depending on the caller’s location, including options for Scotland, Northern Ireland, England, Wales, or overseas.

For those requiring accessible formats, the SSCS8 form is available in large print, Welsh, and Braille, ensuring inclusivity for all applicants.

Legal and Administrative Context

The appeal process governed by the HM Courts & Tribunals Service operates under the legal framework of the UK, ensuring adherence to data protection laws such as the Data Protection Act 2018 and the UK GDPR. This guarantees that personal data submitted during the appeal is handled securely and confidentially.

The entire procedure underscores the UK government’s commitment to providing justice and support for those affected by infected blood products, offering a transparent, accessible, and independent avenue for appeals.